SCHEMBL26699573

SCHEMBL26699573

CCC(C)NCC(O)CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
POLB P06746 1/20 0.39
LMNA P02545 4/20 0.36
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
CNR1 P21554 1/20 0.36
ADRA1A P35348 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TSHR P16473 2/20 0.35
ABCC3 O15438 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7050022 0.85 HPGD (0.44) HPGDHTTPOLBALDH1A1TDP1
SCHEMBL13934087 0.85 HPGD (0.44) HPGDHTTPOLBALDH1A1TDP1
SCHEMBL19091377 0.82 HPGD (0.40) HPGDHTTPOLBALDH1A1TSHR
SCHEMBL11418856 0.79 LMNA (0.35) LMNAALDH1A1TDP1
SCHEMBL11702357 0.79 HPGD (0.41) HPGDHTTPOLBLMNAALDH1A1
SCHEMBL20988048 0.78 LMNA (0.48) LMNAALDH1A1TDP1CNR1ADRA1A
SCHEMBL19091361 0.78 LMNA (0.37) HPGDHTTPOLBLMNAALDH1A1
SCHEMBL19090720 0.78 LMNA (0.48) LMNAALDH1A1TDP1CNR1ADRA1A
SCHEMBL13612890 0.78 LMNA (0.48) LMNAALDH1A1TDP1CNR1ADRA1A
SCHEMBL19091159 0.77 THRB (0.39) HPGDHTTLMNAALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230338415-A1 SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE GLYSCEND, INC. 2023-10-26 US disclosed
US-20230338415-A1 SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE GLYSCEND, INC. 2023-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230338415-A1 SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE SLC10A2, PYGL, SLC10A1 HPGD 2087/4885HTT 1026/4885POLB 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.